421 related articles for article (PubMed ID: 19154261)
61. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors.
Mechtersheimer G; Staudter M; Möller P
Cancer Res; 1991 Feb; 51(4):1300-7. PubMed ID: 1705171
[TBL] [Abstract][Full Text] [Related]
62. Proliferative activity, angiogenesis, and necrosis in peripheral nerve sheath tumors: a quantitative evaluation for prognosis.
Miracco C; Montesco MC; Santopietro R; Spina D; d'Amore ES; Tosi P; Ninfo V
Mod Pathol; 1996 Dec; 9(12):1108-17. PubMed ID: 8972469
[TBL] [Abstract][Full Text] [Related]
63. Intrathoracic peripheral nerve sheath tumors-a clinicopathological study of 75 cases.
Boland JM; Colby TV; Folpe AL
Hum Pathol; 2015 Mar; 46(3):419-25. PubMed ID: 25595633
[TBL] [Abstract][Full Text] [Related]
64. Pathologic classification of peripheral nerve tumors.
Skovronsky DM; Oberholtzer JC
Neurosurg Clin N Am; 2004 Apr; 15(2):157-66. PubMed ID: 15177315
[TBL] [Abstract][Full Text] [Related]
65. Cutaneous melanocytoneuroma: the first case of a distinctive intraneural tumor with dual nerve sheath and melanocytic differentiation.
Weinreb I; Labonte S; Goli H; Chetty R; Ghazarian D
J Cutan Pathol; 2007 Dec; 34 Suppl 1():52-7. PubMed ID: 17997740
[TBL] [Abstract][Full Text] [Related]
66. Neuromesenchyme. The concept of a neurocristic effector cell for dermal mesenchyme.
Reed RJ
Am J Dermatopathol; 1983 Aug; 5(4):385-95. PubMed ID: 6314835
[TBL] [Abstract][Full Text] [Related]
67. Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Malignant, but Not Benign, Peripheral Nerve Sheath Tumors.
Cadwell CR; Yuksek GE; Hirbe AC; Srihari D; LeBoit P; Dahiya S; Pekmezci M
J Neuropathol Exp Neurol; 2021 Mar; 80(4):384-386. PubMed ID: 33212492
[No Abstract] [Full Text] [Related]
68. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
Fullen DR; Garrisi AJ; Sanders D; Thomas D
J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
[TBL] [Abstract][Full Text] [Related]
69. [Neurinomas-neurofibromas].
Goujon JM; Bataille B; Menet E; Lapierre F
Neurochirurgie; 1997; 43(1):35-8. PubMed ID: 9205625
[TBL] [Abstract][Full Text] [Related]
70. Low grade malignant peripheral nerve sheath tumor with mesenchymal differentiation: a case report.
Janczar K; Tybor K; Józefowicz M; Papierz W
Pol J Pathol; 2011 Dec; 62(4):278-81. PubMed ID: 22246916
[TBL] [Abstract][Full Text] [Related]
71. Distribution of neural cell adhesion molecule (NCAM/CD56) in gastrointestinal stromal tumours and their intra-abdominal mesenchymal mimics.
Agaimy A; Wünsch PH
J Clin Pathol; 2008 Apr; 61(4):499-503. PubMed ID: 17923471
[TBL] [Abstract][Full Text] [Related]
72. Galectin-3 expression is ubiquitous in tumors of the sellar region, nervous system, and mimics: an immunohistochemical and RT-PCR study.
Rodriguez FJ; Scheithauer BW; Roncaroli F; Silva AI; Kovacs K; Brat DJ; Jin L
Am J Surg Pathol; 2008 Sep; 32(9):1344-52. PubMed ID: 18670355
[TBL] [Abstract][Full Text] [Related]
73. Foraminal nerve sheath tumors: intermediate follow-up after cyberknife radiosurgery.
Murovic JA; Gibbs IC; Chang SD; Mobley BC; Park J; Adler JR
Neurosurgery; 2009 Feb; 64(2 Suppl):A33-43. PubMed ID: 19165072
[TBL] [Abstract][Full Text] [Related]
74. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas.
Ohata C; Tadokoro T; Itami S
J Dermatol; 2008 Apr; 35(4):215-21. PubMed ID: 18419678
[TBL] [Abstract][Full Text] [Related]
75. What are the CD34+ cells in benign peripheral nerve sheath tumors? Double immunostaining study of CD34 and S-100 protein.
Khalifa MA; Montgomery EA; Ismiil N; Azumi N
Am J Clin Pathol; 2000 Jul; 114(1):123-6. PubMed ID: 10884807
[TBL] [Abstract][Full Text] [Related]
76. Human melanoma cells express functional receptors for thyroid-stimulating hormone.
Ellerhorst JA; Sendi-Naderi A; Johnson MK; Cooke CP; Dang SM; Diwan AH
Endocr Relat Cancer; 2006 Dec; 13(4):1269-77. PubMed ID: 17158770
[TBL] [Abstract][Full Text] [Related]
77. Superficial malignant peripheral nerve sheath tumor with overlying intradermal melanocytic nevus mimicking spindle cell melanoma.
Jackson CR; Minca EC; Kapil JP; Smith SC; Billings SD
J Cutan Pathol; 2016 Dec; 43(12):1220-1225. PubMed ID: 27687011
[TBL] [Abstract][Full Text] [Related]
78. Glial fibrillary acidic protein (GFAP) immunoreactivity in peripheral nerve sheath tumors.
Memoli VA; Brown EF; Gould VE
Ultrastruct Pathol; 1984; 7(4):269-75. PubMed ID: 6543600
[TBL] [Abstract][Full Text] [Related]
79. Chondromyxoid fibroma: a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation.
Nielsen GP; Keel SB; Dickersin GR; Selig MK; Bhan AK; Rosenberg AE
Mod Pathol; 1999 May; 12(5):514-7. PubMed ID: 10349990
[TBL] [Abstract][Full Text] [Related]
80. Plexiform Melanocytic Schwannoma: Report of a Second Case and Overview of a Rare Entity.
Ranson M; Lai J; Van Brenk B; McCalmont TH; Walsh NM
Am J Dermatopathol; 2022 Dec; 44(12):943-947. PubMed ID: 36395450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
